Denis Métivier

Dr. Denis Métivier

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
LBLaurys BOUDIN
Laurys BOUDIN
JMJean-Baptiste Morvan
Jean-Baptiste Morvan
Juliette THARIATJuliette THARIAT
Juliette THARIAT
DMDenis Métivier
Denis Métivier
PMPierre Yves Marcy
Pierre Yves Marcy
DDDavid Delarbre
David Delarbre
Anaplastic thyroid carcinoma (ATC) are highly aggressive malignant tumors with poor overall prognosis despite multimodal therapy. As ATC are extremely rare, no randomized controlled study has been published for metastatic disease. Thyrosine kinase inhibitors, especially lenvatinib and immune checkpoint inhibitors such as pembrolizumab, are emerging drugs for ATC. Few studies have reported the efficacity of pembrolizumab and lenvatinib association, resulting in its frequent off-label use. In this review, we discuss rationale efficacy and safety evidence for the association of lenvatinib and pembrolizumab in ATC. First, we discuss preclinical rationale for pembrolizumab monotherapy, lenvatinib monotherapy and synergistic action of pembrolizumab and lenvatinib in the metastatic setting. We also discuss clinical evidence for immunotherapy and pembrolizumab in ATC through the analysis of studies evaluating immunotherapy, lenvatinib and pembrolizumab lenvatinib association in ATC. In addition, we discuss the safety of this association and potential predictive biomarkers of efficiency.

26 November 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
JMJean-Baptiste Morvan
Jean-Baptiste Morvan
LBLaurys BOUDIN
Laurys BOUDIN
DMDenis Métivier
Denis Métivier
DDDavid Delarbre
David Delarbre
EBEdouard Bouquillon
Edouard Bouquillon
PMPierre Yves Marcy
Pierre Yves Marcy
Internal jugular vein tumor thrombus is an extremely rare condition in thyroid carcinoma, but it does exist. Correlated with greater aggressiveness with a higher incidence of distant metastases at diagnosis and a higher recurrence rate, this important prognostic element should be systematically investigated by ultrasound operators in all patients presenting with thyroid carcinoma. The patient’s follow-up must be careful. This can be a trap that surgeons must look for in their preoperative checklist. We report the case of a 58-year-old woman with an IJV thrombus associated with multiple bone metastases. She underwent successful surgical treatment, and postoperative pathology showed a poorly differentiated follicular carcinoma of the thyroid and a tumor thrombus in the internal jugular vein.